Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508378 · ClinicalTrials.gov registry record
Chemotherapy-Related Toxicities In Ovarian Cancer Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 288
- Enrollment target
NCT00508378: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00508378 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00508378 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 288 participants
- Enrollment target
Study Summary
Primary Objectives: 1. To assess the preferences of women with ovarian cancer, their clinical caregivers, familial caregivers, and a control group for toxicities associated with chemotherapy. * To compare preferences of women with ovarian cancer to preferences of their clinical caregivers. * To compare preferences of women with ovarian cancer to preferences of their familial caregivers. * To compare preferences of women with ovarian cancer to preferences of a women in the control group. 2. To prospectively collect quality of life data from women with ovarian cancer. 3. To prospectively collect symptom assessment data from women with ovarian cancer.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2001-01 |
| Est. Completion | 2020-11-03 |
What the finished NCT00508378 record still lists
NCT00508378 is an observational study that tracks outcomes without assigning an intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00508378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00508378 about?
NCT00508378 is a clinical study titled "Chemotherapy-Related Toxicities In Ovarian Cancer Patients". Primary Objectives: 1. To assess the preferences of women with ovarian cancer, their clinical caregivers, familial caregivers, and a control group for toxicities associated with chemotherapy. * To compare preferences of women with ovarian cancer to preferences of their clinical caregivers. *...
What is the current status of trial NCT00508378?
This trial is currently completed. The enrollment target is 288 participants. The study started on 2001-01. Estimated completion is 2020-11-03.
What interventions are being tested in trial NCT00508378?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00508378?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia